by PRI | Dec 4, 2023 | Microbiome Product Developer
Damien Rei CEO Startup developing gut microbiota derived treatment against neurodegenerative diseases...
by PRI | Dec 6, 2022 | Microbiome Product Developer
Pedro Correa de Sampaio CEO Neobe is building a platform for the engineering of live biotherapeutics aimed at removing stromal barriers to immune infiltration in solid tumours, in order to enable existing immunotherapies in current non responding cancer patients....
by PRI | Jun 21, 2022 | Microbiome Product Developer
Nikole Kimes CEO & Founder Siolta Therapeutics is a clinical-stage biotech company on a mission to alleviate the suffering of millions impacted by chronic inflammatory diseases through novel microbiome-based medicines....
by PRI | Jun 20, 2022 | Microbiome Product Developer
Tomas de Wouters Co-Founder & CEO Pioneering the development of microbiome-based therapies using proprietary tools for their design and production....
by PRI | Jun 20, 2022 | Microbiome Product Developer
Katja Conrath Chief Scientific Officer Unlocking the full potential of the gut microbiome for development of effective therapeutics through our proprietary CORAL™ consortia optimization and single-process manufacturing technology....
by PRI | Jun 20, 2022 | Microbiome Product Developer
Adam Wilkinson VP Pre-Clinical Development Microbiome biomarker and drug development company with a world-leading microbiome analysis platform....
